STRIDES PHARMA SCIENCE LTD.
Market Cap.(`)
|
5884.13 Cr.
|
P/BV
|
2.59
|
Book Value (`)
|
246.48
|
52 Week High/Low ( ` )
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Book Closure
|
09/09/2024
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.39
|
You can view the
Consolidated
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -7.76 | -22.49 | -51.28 | 29.96 | 5.68 |
Diluted EPS (Rs.) | -7.76 | -22.49 | -51.28 | 29.92 | 5.68 |
Cash EPS (Rs.) | 32.87 | 35.02 | -14.53 | 62.65 | 34.78 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 225.43 | 238.73 | 265.39 | 313.78 | 289.69 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 225.43 | 238.73 | 265.39 | 313.78 | 289.69 |
Revenue From Operations / Share (Rs.) | 440.82 | 408.44 | 341.94 | 369.74 | 307.26 |
PBDIT / Share (Rs.) | 85.20 | 57.64 | 12.46 | 76.52 | 63.53 |
PBIT / Share (Rs.) | 61.18 | 30.70 | -13.49 | 53.52 | 44.14 |
PBT / Share (Rs.) | 6.40 | -0.10 | -60.33 | 41.62 | 18.08 |
Net Profit / Share (Rs.) | 8.86 | 8.08 | -40.48 | 39.65 | 15.39 |
NP After MI And SOA / Share (Rs.) | -7.68 | -22.44 | -51.25 | 29.93 | 4.06 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 19.32 | 14.11 | 3.64 | 20.69 | 20.67 |
PBIT Margin (%) | 13.87 | 7.51 | -3.94 | 14.47 | 14.36 |
PBT Margin (%) | 1.45 | -0.02 | -17.64 | 11.25 | 5.88 |
Net Profit Margin (%) | 2.00 | 1.97 | -11.83 | 10.72 | 5.00 |
NP After MI And SOA Margin (%) | -1.74 | -5.49 | -14.98 | 8.09 | 1.32 |
Return on Networth / Equity (%) | -3.32 | -9.23 | -19.51 | 9.66 | 1.43 |
Return on Capital Employeed (%) | 18.99 | 7.59 | -3.39 | 11.22 | 10.95 |
Return On Assets (%) | -1.20 | -3.05 | -6.59 | 3.82 | 0.59 |
Long Term Debt / Equity (X) | 0.31 | 0.51 | 0.35 | 0.31 | 0.23 |
Total Debt / Equity (X) | 1.14 | 1.26 | 1.18 | 0.68 | 0.72 |
Asset Turnover Ratio (%) | 0.64 | 0.54 | 0.31 | 0.32 | 0.26 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.03 | 1.08 | 0.98 | 1.03 | 0.93 |
Quick Ratio (X) | 0.64 | 0.70 | 0.64 | 0.59 | 0.62 |
Inventory Turnover Ratio (X) | 1.18 | 1.24 | 1.09 | 1.43 | 1.29 |
Dividend Payout Ratio (NP) (%) | -19.18 | 0.00 | 0.00 | 6.67 | 429.50 |
Dividend Payout Ratio (CP) (%) | 9.02 | 0.00 | 0.00 | 3.77 | 74.39 |
Earning Retention Ratio (%) | 119.18 | 0.00 | 0.00 | 93.33 | -329.50 |
Cash Earning Retention Ratio (%) | 90.98 | 0.00 | 0.00 | 96.23 | 25.61 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 2.49 | 1.99 | 0.63 | 4.57 | 3.65 |
Interest Coverage Ratio (Post Tax) (%) | 1.69 | 1.27 | 0.32 | 2.99 | 2.47 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 9361.60 | 5003.14 | 5740.37 | 9337.55 | 4551.74 |
EV / Net Operating Revenue (X) | 2.31 | 1.36 | 1.87 | 2.82 | 1.65 |
EV / EBITDA (X) | 11.96 | 9.61 | 51.31 | 13.61 | 8.00 |
MarketCap / Net Operating Revenue (X) | 1.78 | 0.70 | 1.01 | 2.28 | 1.05 |
Retention Ratios (%) | 119.18 | 0.00 | 0.00 | 93.32 | -329.50 |
Price / BV (X) | 3.38 | 1.18 | 1.32 | 2.73 | 1.14 |
Price / Net Operating Revenue (X) | 1.78 | 0.70 | 1.01 | 2.28 | 1.05 |
EarningsYield | -0.01 | -0.07 | -0.14 | 0.03 | 0.01 |